Skip to main content

Animations

MJFF Publications

6311 - 6320 of 8587 Results
Title
Year
  • Year
  • 2016
  • 2022
  • 2021
  • 2024
  • 2016
  • 2018
  • 2023
  • 2020
  • 2015
  • 2022
  • Summary Details
    RESTRICTED
    Title: Motor and nonmotor heterogeneity of LRRK2‐related and idiopathic Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26614
    Best OA location URL:
    Citation Count: 116
  • Summary Details
    OPEN
    Title: Systematic Functional Analysis of PINK1 and PRKN Coding Variants
    Journal Name: Cells
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/cells11152426
    Citation Count: 18
  • Summary Details
    OPEN
    Title: LRRK2-phosphorylated Rab10 sequesters Myosin Va with RILPL2 during ciliogenesis blockade
    Journal Name: Life Science Alliance
    Publisher: Life Science Alliance, LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.26508/lsa.202101050
    Citation Count: 48
  • Summary Details
    RESTRICTED
    Title: Parkinson's Disease Associated with G2019S LRRK2 Mutations without Lewy Body Pathology
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.14068
    Best OA location URL:
    Citation Count: 4
  • Summary Details
    OPEN
    Title: LRRK2 variation and dementia with Lewy bodies
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2016.07.015
    Citation Count: 38
  • Summary Details
    OPEN
    Title: Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trial
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.10.005
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Profiling migraine patients according to clinical and psychophysical characteristics: clinical validity of distinct migraine clusters
    Journal Name: Neurological Sciences
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s10072-023-07118-8
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Association study of DNAJC13, UCHL1, HTRA2, GIGYF2, and EIF4G1 with Parkinson's disease
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.10.019
    Citation Count: 30
  • Summary Details
    RESTRICTED
    Title: Effect of selective LRRK2 kinase inhibition on nonhuman primate lung
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.aaa3634
    Best OA location URL:
    Citation Count: 334
  • Summary Details
    OPEN
    Title: Regulation of Αlpha-Synuclein Gene (SNCA) by Epigenetic Modifier TET1 in Parkinson Disease
    Journal Name: International Neurourology Journal
    Publisher: Korean Continence Society
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.5213/inj.2222206.103
    Citation Count: 10
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.